Journal List > J Vet Sci > v.12(2) > 1041088

Kwon, Park, Shim, Jeong, Cho, Ahn, and Kim: Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model

Abstract

The purpose of our study was to create a novel rat aorta stent implantation model. Stainless steel bare metal stents (BMS) or paclitaxel-eluting stents (PES) were implanted in male Sprague-Dawley rats (BW 400 ± 20 g). Two and four weeks after stent implantation, the aorta were collected, fixed with 2% glutaraldehyde, and cut into two segments. One segment was used for scanning electron microscopy analysis to evaluate re-endothelialization, and the other segment was used to calculate the neointimal area. At 2 weeks after stenting, the appearance of neointimal hyperplasia was less in the PES group than in the BMS group. At 4 weeks after stenting, no significant difference in neointimal hyperplasia was observed between two groups. On the other hand, the PES group showed more thrombus formation and less re-endothelialization compared to the BMS group. This study demonstrated the ability of a novel rat model of aorta stenting via a common carotid artery to measure the efficacy and safety of commercially available drug-eluting stents.

Introduction

Atherosclerotic vascular disease and the resulting sequelae remain the leading cause of death in developed countries worldwide. Stenting is the most frequently performed percutaneous intervention for the treatment of coronary artery disease. However, re-occlusion due to stent thrombosis in the early period and in-stent restenosis in the later period after stent deployment are principal drawbacks of coronary stenting. To attenuate in-stent restenosis, many researchers have studied the effects of new polymers, metals, stent architecture, and drugs on the inhibition of neointimal hyperplasia.
The animal models most commonly used to assess vascular responses to stent implantation are the porcine coronary artery model [19,27] and the rabbit iliac artery model [2,13]. The porcine coronary artery stenting model [11,24] is suitable for research because the porcine heart is similar to the human heart in terms of pathologic and physiologic vascular responses. However, the rapid growing pigs results in a high cost of breeding. The rabbit iliac artery stenting model [7,13] has the advantage of a low cost but the pathologic and physiologic responses of rabbits differ from those in humans. In addition, it is widely recognized that arterial repair after stent placement in animals occurs more rapidly than in humans although the sequence of biological events associated with healing are remarkably similar [28]. However, Finn et al. [9] reported a significant difference in the rate of healing between the porcine model and the rabbit model. After placement of a bare metal stent (BMS), the porcine model showed completed endothelialization by 14 days whereas it took 21 days to complete this process in the rabbit model.
Previous studies in the porcine or rabbit model used both drug-eluting stents and BMS [2,4]. In this study, to demonstrate the validity of our novel rat model in comparison with these previous animal models, we implanted BMS and paclitaxel-eluting stents (PES) and assessed stent re-endothelialization, neointimal hyperplasia, and thrombus formation 2 and 4 weeks after stent implantation.

Materials and Methods

Animal care, stent deployment, and aortogram

All animal protocols were approved by the Chonnam National University Animal Care and Use Committee (CNU IACUC-H-2009-18). Male Sprague-Dawley rats were purchased from Samtako (Korea). All rats (b.w. 400 ± 20 g) were fed a normal pelleted diet and were given water ad libitum. Starting 1 week before stent implantation and continuing throughout the study period, the rats' drinking water contained aspirin (3.25 mg/kg; Bayer Vital, Germany) and clopidogrel (0.75 mg/kg, Plavix; Sanofi-Aventis, USA).
In the baseline study, a total of 14 rats underwent an aortogram and surgery. We measured the aorta size of 10 rats by angiogram before stent implantation. To select the optimal stent size (diameter and length), balloon pressure, and stent-to-artery ratio, the aorta size of the rats that underwent stent implantation was measured by angiogram. A balloon pressure of 9 atm resulted in a stent-to-artery ratio into 1:1.2. A BMS (n = 6, Liberté 3.5 × 20 mm; Boston Scientific, USA) or a PES (n = 6, Taxus Liberté 3.5 × 20 mm; Boston Scientific, USA) was deployed at 9 atm in the rats.
For stent implantation, the rats were anesthetized with an intraperitoneal injection of ketamine (50 mg/kg; Bayer Animal Health, Korea) and xylazine (6.7 mg/kg; Bayer Animal Health, Korea), and the left common carotid artery was surgically exposed. The proximal portion of the left common carotid artery was ligated with 5-0 silk thread. The distal portion was then occluded by a vessel clamp to block blood flow and a carotid cut down was performed at the mid portion. Under fluoroscopic guidance [7,18], the stent catheter was advanced to the thoracic aorta via the left common carotid arteriotomy. A 0.36 mm percutaneous transluminal coronary angioplasty (PTCA) guide wire was advanced into the thoracic aorta. A BMS or PES with a balloon-to-artery ratio ranging from 1:1.2 to 1:1.3 was placed at the desired location in the thoracic aorta and inflated to 9 atm of balloon pressure. After stent deployment, the animals were allowed to recover in their normal housing at the animal care facility. The animals were monitored daily until the subsequent experimental procedures and euthanasia 2 or 4 weeks after stent placement.
Aortography was performed 2 or 4 weeks after stent deployment (Fig. 1A) using a contrast agent (Visipaque; Amersham Health, Ireland). An angiography catheter (18 G radiology needles; BD, USA) was introduced through the right common carotid artery and advanced to the thoracic aorta to deliver the contrast agent. Aorta size was calculated by quantitative angiography before stent implantation. Stent size and balloon pressure were also determined. The stent-to-artery ratio was calculated by dividing the post-implant aorta diameter by the pre-implant aorta diameter.

Tissue preparation and histomorphometric analysis

At 2 and 4 weeks after stent implantation, the rats were anesthetized with an intraperitoneal injection of ketamine and xylazine. After the final aortogram, the aorta was flushed gently with a 0.9% saline solution and perfusion fixation was performed with 2.5% glutaraldehyde. The stented aorta was harvested with at least 1 cm of the proximal and distal margin. After an additional 24 h of immersion fixation with 2.5% glutaraldehyde, the stented aorta was cut into two segments.
One segment of the stented aorta was used for scanning electron microscopy (SEM) analysis. SEM analysis was conducted by following standard procedures. In brief, the stented aorta was fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (Sigma Aldrich, USA) for 2 h and then OsO4 for 90 min, followed by dehydration through a series of alcohols. The samples then underwent critical point drying before being coated with evaporated gold and observed under an S-3500N scanning electron microscope (Hitachi, Japan). The re-endothelialization ratio was calculated by using NIS-Elements (version 3.00 SP7; Nikon, Japan).
The other segment of the stented aorta was placed in 10% formalin for an additional 24 h. Cross-sections were prepared from the segment by embedding the tissue in acrylic plastic and cutting sections 75 µm-thick. All sections were stained with hematoxylin and eosin. Histomorphometric analysis was carried out using Nis-Elements. The neointimal area was calculated as the media area minus the inner luminal area (neointimal area = media area - inner luminal area). These areas were determined in each section, averaged, and expressed as the absolute area in mm2. Additionally, the uncovered strut ratio was determined by microscopic observation and calculated as exposed strut number / total strut number. The focal thrombus ratio was calculated as thrombus-containing strut number / total strut number as found by microscopic observation. These were averaged over all stained sections. At SEM analysis, the re-endothelization percentage (%) was calculated as the strut area minus the uncovered area divided by the strut area (re-endothelization percentage (%) = strut area - uncovered area / strut area) (Fig. 4Ab).

Statistical analysis

Measurements for each stented aorta (total sections from the mid to distal portion) were averaged to produce a mean value per stent. Tests for statistical significance were two-tailed, and significance was established by a p-value < 0.05 (v 16.0; SPSS, USA). Unless otherwise noted, data are represented as the mean ± SD.

Results

Establishment of the rat aorta stent model

The total procedure time for stent implantation in the rat aorta was approximately 15 to 20 min. Four rats died during surgery due to bleeding from the carotid artery at the site of incision. All stented aorta (n = 12) in the surviving rats were patent. The operation procedure is illustrated in Fig. 1A. The left common carotid artery was exposed and PTCA guide wire was inserted into the carotid artery. The stent was then inserted into the thoracic aorta via the guide wire (Figs. 1B and C). At 2 or 4 weeks after stent implantation, angiography was performed with an 18 G IV catheter in the right carotid artery (Fig. 1D). Quantitative angiograms at each time point (2 or 4 weeks after stenting) showed that the stents were implanted with similar stent-to-artery ratios.

Histomorphometric analysis

The neointimal area was larger in the BMS group (0.262 ± 0.010 mm2) than in the PES group (0.170 ± 0.014 mm2) at 2 weeks following stent placement (p < 0.05) (Figs. 2A and 3A). However, no significant difference in the neointimal area was observed between the two groups [BMS group: 0.567 ± 0.055 mm2 vs. PES group: 0.618 ± 0.089 mm2 (p > 0.05)] at 4 weeks (Figs. 2A and 3C). The uncovered strut ratio was 38.3 ± 16.5% in the BMS group and 84.2 ± 1.1% in the PES group at 2 weeks, and 8.3 ± 4.0% in the BMS group and 45.0 ± 7.1% in the PES group at 4 weeks (Fig. 2B). The focal thrombus ratio was 0.0 ± 0.0% in the BMS group and 29.4 ± 8.9% in the PES group at 2 weeks and 5.0 ± 7.1% in the BMS group and 51.3 ± 8.3% in the PES group at 4 weeks. In addition, thrombi were detected only in the neointimal area (Figs. 2C and 3D).

SEM evaluation of re-endothelialization

At SEM analysis, the portion of the stent struts that remained uncovered was less in the BMS group than in the PES group at 2 weeks after stent implantation. Stent detachment was observed in the PES group (Fig. 4B). As seen in Figs. 4C and D, the portion of the stent struts that was covered increased in both groups at 4 weeks. The BMS struts were mostly covered (93 ± 4%), but the PES struts were not sufficiently covered (53 ± 18%) (p < 0.05). The strut was covered by endothelial cells in the BMS group (Fig. 4E, green arrows). In the PES group, non-endothelial cells such as inflammatory cells and platelets were detected on the stent surface (Fig. 4E, yellow arrows).

Discussion

In this study, we developed a novel aorta stent model in rats that is similar to percutaneous implantation of a coronary stent in human, and compared the effects of BMS with those of PES. Our aorta stent model in rats has several advantages. First, the stent site was not exposed to the external environment. Therefore, it was protected from complications caused by inflammation and tissue adhesion. In addition, stent implantation was performed using human stent implantation devices. Rats are ideal for biochemical and biological analyses compared to pig models because they can be easily studied with various commercially available antibody and ELISA kits. In addition, rats have various disease models such as transgenic, obese, atherosclerotic, diabetic, and hypertensive strains Moreover, knockout rat strains are becoming increasingly available.
Langeveld et al. [18], Indolfi et al. [12], and Finn et al. [7] used an open abdominal aorta stent rat model or deployed a small-caliber stent into the carotid artery in the rat. The open abdominal aorta model is very useful, but exposure of the abdominal cavity and abdominal aorta to the external environment may cause reactions such as inflammation and adhesion. Additionally, the rat carotid artery cannot be accessed by commercially manufactured coronary stents. Our model did not require microsurgical equipment or special skills. Furthermore, we used commercially available BMS and PES in the rat thoracic aorta.
In previous report, PES has been shown to reduce the rate of restenosis and late lumen loss compared to BMS, resulting in a significant reduction in the need for target vessel revascularization [23]. However, an increased risk of late stent thrombosis (defined as thrombosis ≥ 30 days after stent deployment) has been identified as a major safety concern [1,3,6,14-17,21,22,25,26]. This concept is based on clinical autopsy and intracoronary angioscopic studies [5,10,16]. In the present study, the aorta stent model in SD rats showed vascular reaction patterns of re-endothelialization, neointimal induction, and thrombus formation similar to those in a swine model [8-10]. However, the induction of neointimal hyperplasia was weaker in our rat model than in the swine model.
By SEM analysis, the percentage of the stent area covered in the rats was found to be over 90% in the BMS group and about 50% in the PES group at 4 weeks after stent implantation. Experiments in a porcine coronary stent model have suggested that re-endothelialization was complete at 28 days after stent placement [8]. However, in another study, re-endothelialization was clearly delayed when a PES was implanted in a rabbit iliac artery [4].
The histological analysis showed that the neointimal area was increased at 4 weeks compared to 2 weeks. The extent of neointimal hyperplasia was less in the PES group than in the BMS group at 2 weeks. In the PES group, decreased neointimal hyperplasia was related to the paclitaxel coating of the stent strut surface. No difference in neointimal hyperplasia was observed 4 weeks after stenting between the BMS and PES group. This phenomenon might be called "late catch-up." In the BMS group, neointimal formation gradually increased between 2 and 4 weeks after stent implantation. In the PES group, however, reduced neointimal formation observed until 2 weeks suddenly increased between 2 and 4 weeks after stent implantation.
Thrombus formation could be a possible factor in late catch-up. In our study, thrombi were detected in the PES group in the outer area of the neointima at 2 weeks and in the inner area of the neointima at 4 weeks. From our experiments, we can hypothesize that the PES inhibited neointimal formation during the early phase, but caused thrombus formation and restenosis during the later phase.
In conclusion, we have demonstrated the creation of a novel model of aorta stenting via the common carotid artery in rats. Our model showed similar vascular responses after implantation of BMS and PES in normal rat aorta compared to pig and rabbit models. This model had the disadvantage of weaker neointimal hyerplasia compared to the pig coronary artery stent model [20], but had the advantages of enabling the detection of thrombi, re-endothelialization analysis, histomorphometric analysis, easy handling, and low cost. In addition, our model will allow relative long-term follow-up and research on aged animals because of the short life-span.

Figures and Tables

Fig. 1
Establishment of a novel aorta stent implantation procedure in rats. Representative illustrations and fluoroscopic angiographs of the implantation of a bare metal stent or paclitaxel-eluting stent in the thoracic aorta. (A) Operation procedure. (B) and (C) Operation procedure involved a guide wire that was advanced in the thoracic aorta after excision of the left common carotid artery and a stent inserted into the thoracic aorta. (D) Follow-up thoracic angiography was performed with a catheter in the right common carotid artery.
jvs-12-143-g001
Fig. 2
(A) 2 weeks (wk) and (B) 4 wk after implantation of the bare metal stent (BMS) or paclitaxel-eluting stent (PES). (C) Thrombus in the outer and inner area of the neointima at 4 wk. Scale bars = Aa and b, Ba and b: 1 mm; Ac and d, Bc and d, C: 50 µm. H&E stain.
jvs-12-143-g002
Fig. 3
Histomorphometric results of BMS or PES implantation. (A) Neointimal area. (B) Representation of neointimal area, media area (green line) and inner luminal area (square line). (C) Uncovered strut ratio. (D) Focal thrombus ratio. BMS 2 wk vs. PES 2 wk (*p < 0.05). BMS 4 wk vs. PES 4 wk (**p < 0.05), BMS 2 wk vs. BMS 4 wk (#p < 0.05), PES 2 wk vs. PES 4 wk (##p < 0.05).
jvs-12-143-g003
Fig. 4
Scanning electron microscopy photographs of BMS and PES in rat aorta. (A) Representation of strut area (blue) and uncovered area (red). (B) BMS and PES at 2 wk and (C) at 4 wk. (D) The covered stent ratio at 4 wk after stent implantation. (E) High magnification. Endothelial cells (green arrow), inflammatory cells (yellow arrow), and stent strut (red arrow). *p < 0.05. Ba and Ea: BMS 2 wk, Bb and Eb: PES 2 wk, Ca and Ec: BMS 4 wk, Cb and Ed: PES 4 wk. Scale bars = Aa: 500 µm, B and C: 1 mm, Ea and b: 100 µm, Ec and d: 50 µm.
jvs-12-143-g004

Acknowledgments

This study was supported by a grant (A084869) of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs and National Research Foundation (2009-0076709, 2010-0020261) of Korea Grant funded by the Korean Government, Korea.

References

1. Alhan C, Karabulut H, Senay S, Cagil H, Toraman F. Endovascular treatment of occlusive abdominal aortic thrombosis. Heart Vessels. 2010. 25:70–72.
crossref
2. Busseuil D, Collin B, Rioufol G, Korandji C, Zeller M, Maingon P, Briot F, Cottin Y, Rochette L. Combining sirolimus-eluting stents and external irradiation in cholesterol-fed rabbits increased incomplete stent apposition and decreased re-endothelialization. J Cardiovasc Pharmacol. 2009. 53:318–324.
crossref
3. Curfman GD, Morrissey S, Jarcho JA, Drazen JM. Drug-eluting coronary stents - Promise and uncertainty. N Engl J Med. 2007. 356:1059–1060.
crossref
4. Drachman DE, Edelman ER, Seifert P, Groothuis AR, Bornstein DA, Kamath KR, Palasis M, Yang D, Nott SH, Rogers C. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol. 2000. 36:2325–2332.
crossref
5. Ertaş G, van Beusekom HM, van Giessen WJ. Late stent thrombosis, endothelialisation and drug-eluting stents. Neth Heart J. 2009. 17:177–180.
crossref
6. Farb A, Boam AB. Stent thrombosis redux - The FDA perspective. N Engl J Med. 2007. 356:984–987.
crossref
7. Finn AV, Gold HK, Tang A, Weber DK, Wight TN, Clermont A, Virmani R, Kolodgie FD. A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases. J Vasc Res. 2002. 39:414–425.
crossref
8. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005. 112:270–278.
crossref
9. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007. 27:1500–1510.
10. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007. 115:2435–2441.
crossref
11. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 1999. 99:2164–2170.
crossref
12. Indolfi C, Esposito G, Stabile E, Cavuto L, Pisani A, Coppola C, Torella D, Perrino C, Di Lorenzo E, Curcio A, Palombini L, Chiariello M. A new rat model of small vessel stenting. Basic Res Cardiol. 2000. 95:179–185.
crossref
13. Jang HS, Nam HY, Kim JM, Hahm DH, Nam SH, Kim KL, Joo JR, Suh W, Park JS, Kim DK, Gwon HC. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model. Catheter Cardiovasc Interv. 2009. 74:881–888.
crossref
14. Johnson GJ, Griggs TR, Badimon L. The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular and Molecular Models of Thrombosis and Haemostasis of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 1999. 81:835–843.
15. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbæk H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007. 356:1030–1039.
crossref
16. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, Mintz GS, Nagata S. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol. 2006. 47:2108–2111.
17. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L. the SCAAR Study Group. Long-term outcomes with drug-Eluting stents versus Bare-Metal stents in Sweden. N Engl J Med. 2007. 356:1009–1019.
crossref
18. Langeveld B, Roks AJM, Tio RA, van Boven AJ, van der Want JJL, Henning RH, van Beusekom HMM, van der Giessen WJ, Zijlstra F, van Gilst WH. Rat abdominal aorta stenting: a new and reliable small animal model for in-stent restenosis. J Vasc Res. 2004. 41:377–386.
crossref
19. Li J, Jabara R, Pendyala L, Otsuka Y, Shinke T, Hou D, Robinson K, Chronos N. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents. JACC Cardiovasc Interv. 2008. 1:279–285.
crossref
20. Lim SY, Jeong MH, Hong SJ, Lim DS, Moon JY, Hong YJ, Kim JH, Ahn Y, Kang JC. Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis. Circ J. 2008. 72:463–468.
crossref
21. Maisel WH. Unanswered questions - Drug-eluting stents and the risk of late thrombosis. N Engl J Med. 2007. 356:981–984.
crossref
22. Mauri L, Hsieh WH, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-Eluting stents. N Engl J Med. 2007. 356:1020–1029.
crossref
23. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, Weissman NJ, Mintz GS. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003. 348:1537–1545.
crossref
24. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, Klugherz BD, Papandreou G, Narayan P, Leon MB, Yeung AC, Tio F, Tsao PS, Falotico R, Carter AJ. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation. 2001. 104:1188–1193.
crossref
25. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007. 356:989–997.
crossref
26. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007. 356:998–1008.
crossref
27. Suzuki Y, Ikeno F, Koizumi T, Tio F, Yeung AC, Yock PG, Fitzgerald PJ, Fearon WF. In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation. JACC Cardiovasc Interv. 2008. 1:168–173.
crossref
28. Virmani R, Kolodgie FD, Farb A, Lafont A. Drug eluting stents: are human and animal studies comparable? Heart. 2003. 89:133–138.
crossref
TOOLS
Similar articles